Generic drug imports unlikely to face tariffs - report
Source: SeekingAlpha
2025-10-09 04:22:22 ET
More on pharma sector
- Why The Pfizer-Trump Deal Is A Win For Branded Pharma, But Not For Consumers
- President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio
- HHS ramps up drug pricing efforts with another proposed rule sent for review
- Trump holding off on pharma tariffs to negotiate more deals - report
Read the full article on Seeking Alpha
For further details see:
Generic drug imports unlikely to face tariffs - report
ProShares Ultra Health Care
NASDAQ: RXL
RXL Trading
1.9% G/L:
$49.99 Last:
12,602 Volume:
$49.05 Open:
